that's true once folks gets exposed to what they are actually getting injected with.
an experimental gene therapy that's NOT been approved by FDA. which has to pass phase 3 safety trials. so far NO mRNA gene therapy has passed long term animal tests. this is after decades of trying. excellent initial antibody response in animals, only to die say a year later when exposed to target virus.
scientist call this .. trojan horse symptom when exposed to target virus in wild. virus now has a gateway in.
further .. white blood cells which normally swoops in to kill invading bacteria and viruses. keeping it simple without bringing in subtypes. let's call it type 1 and 2. type 1 brings in all the desired reactions like cytoclines, etc. then type 2 comes in shuts down type 1 and cleans up.
potential problem with mRNA "vaccines" aka gene therapy create spike proteins, which shuts down type 2 white blood cells. meanwhile type 1 white blood cells doing it's job, now goes wild into a cytocline storm, killing test animals 20% to 50% in long term trials.
this is without getting into a host of other potential side effects including possible long term fertility issues. including damaging nutrients necessary for placenta to develop. this possibly goes for makes too ... very scary!
then factor .. above risks vs C-19 with 99.5% survival for under age 70 folks without treatment.
latest treatment with ivermectin/zinc/doxycycline flat shuts down C-19. hands down I'd rather get C-19 instead of taking an experimental gene theraphy that NO one knows what long term side effects will be.
everything above is typed from memory and folks are accusing me of not understanding technologies involved.
The Moderna COVID-19 (mRNA-1273) vaccine: what you need to know https://www.who.int/
Does it prevent infection and transmission?
We do not know whether the vaccine will prevent infection and protect against onward transmission. Immunity persists for several months, but the full duration is not yet known. These important questions are being studied.
In the meantime, we must maintain public health measures that work: masking, physical distancing, handwashing, respiratory and cough hygiene, avoiding crowds, and ensuring good ventilation.
Is it safe?
While this vaccine has yet to be approved by WHO for an Emergency Use Listing
Those who experience an immediate severe allergic reaction to the first dose should not receive additional doses.
Longer-term safety assessment involves continued follow up of clinical trial participants, as well as specific studies and continued surveillance of secondary effects or adverse events of those being vaccinated in the roll out.